Metraipolis › archive › dc_bc4b3dfe262b

The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or… — Europe PMC PMID:42199866

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42199866
DOI
10.3389/fphar.2026.1712949
License (as archived)
solo-consultazione
Archived
2026-11-02T11:29:53.051Z
SHA-256 of the archived text
d82e0e4861927f0eb012e9131c66c9ce6a00443c39280f3346719e212a47b783
Stable URL of this page
https://metraipolis.com/documento/dc_bc4b3dfe262b

How to cite

The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or… — Europe PMC PMID:42199866 — Europe PMC (en), https://europepmc.org/article/MED/42199866 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc4b3dfe262b (Metraipolis archive dc_bc4b3dfe262b, sha256 d82e0e4861927f0eb012e9131c66c9ce6a00443c39280f3346719e212a47b783)
BibTeX
@misc{dcbc4b3dfe262b,
  title = {The impact of NK1 receptor antagonist selection on chemotherapy-related adverse events: a retrospective study of adverse events in paclitaxel or… — Europe PMC PMID:42199866},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42199866},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc4b3dfe262b; sha256 d82e0e4861927f0eb012e9131c66c9ce6a00443c39280f3346719e212a47b783},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42199866. Agents can read the archived copy with the MCP tool read_document.